Category Archives: Uncategorized

“The Truly Staggering Cost Of Inventing New Drugs”

Another provocative piece in Forbes  that implies the cost of developing a new drug could be as high as $12B!!  This approach has a number of flaws (as does: ”Best Drug Companies.. “)  All produce (provoke?) some interesting insights from commenters.    Funny how … Continue reading

Posted in Uncategorized | Leave a comment

 

Share

In-progress: NME’s .vs mergers

Note: The following focuses on New Medical Entities (NME’s.)  These are defined as the novel, initial member of a chemical family for a drug.  The data is derived from the public FDA database on approved drugs for past years.  From … Continue reading

Posted in Uncategorized | 3 Comments

 

Share

Continued laments on R&D performance

Poor performance of Pharma R&D seems to have never left the newsservices or the hearts of all in the industry.  It is interesting to see the stories of 2011 echoing back for a decade.  Here are some current “news” items … Continue reading

Posted in Core Learnings, Financial, General Interest, Uncategorized | 1 Comment

 

Share

Corante’s “Big Pharma’s Lost Stock Market Decade”

Take a look at the posting and discussions on Derek Lowe’s excellent blog: http://pipeline.corante.com/archives/2010/12/13/big_pharmas_lost_stock_market_decade.php#comments     Another version of his chart is here, showing the last two years .vs. Lowe’s decade view.  It reveals the same result: the industry has underperformed the … Continue reading

Posted in Uncategorized | Leave a comment

 

Share